A comprehensive view of Bristol-Myers Squibb Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Australia Patent: Bristol-Myers Squibb Files Application for 'Imidazo(1,2-a)pyridine and (1,2,4)triazolo(1,5-a)pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis'
Published: March 17, 2023 by Australian Government
Australia Patent: Bristol-Myers Squibb Files Application for '1H-benzo(d)imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis'
Published: March 17, 2023 by Australian Government
Patent Issued for Antibodies against TIM3 and uses thereof (USPTO 11591392)
Published: March 17, 2023 by Immunotherapy Daily
INTERNATIONAL PATENT: BRISTOL-MYERS SQUIBB COMPANY FILES APPLICATION FOR "COMPOUND USEFUL FOR PET-IMAGING OF BRUTON'S TYROSINE KINASE"
Published: March 16, 2023 by U.S. Fed News
Bristol Myers Squibb Submits Chinese Patent Application for Complex Biomarkers for Cancer Therapy
Published: March 16, 2023 by Medical Patent News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count